Abaloparatide
- Part D specialty tier in 77% of formularies (2026Q3)
- Tymlos
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Abaloparatide: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Before first use, store TYMLOS under refrigeration between 2°C to 8°C (36°F to 46°F).
- Freezing
- Do not freeze
Label statement
Do not freeze or subject to heat.
- Room temperature
- up to 30 days at or below 25°C (77°F)
Label statement
During 30 days of use: After first use, store the TYMLOS pen for up to 30 days at room temperature between 68°F to 77°F (20°C to 25°C).
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (8)
- Before first use, store TYMLOS under refrigeration between 2°C to 8°C (36°F to 46°F).
- After first use, store for up to 30 days at 20°C to 25°C (68°F to 77°F).
- Do not freeze or subject to heat.
- Before first use, store TYMLOS pens in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Do not store pens with the needle attached.
- Do not freeze the TYMLOS pen or expose it to heat.
- During 30 days of use: After first use, store the TYMLOS pen for up to 30 days at room temperature between 68°F to 77°F (20°C to 25°C).
- Do not store the TYMLOS pen with needle attached.
FDA label version 19, effective August 11, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.